AHA Advocacy Alliance for the 340B Discount Drug Program
Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to tax-payer supported health care facilitates that care for uninsured and low-income people. Participating hospitals depend on the 340B drug discount program to provide pharmacy services to some of their most vulnerable patients. The AHA 340B Advocacy Alliance seeks to promote the value that this program provides to patients and communities and fight any efforts to scale back the program. In addition, the alliance will advocate for extending the 340B discounts to the purchases of drugs used during inpatient hospital stays; the expansion of the program would be a win-win for taxpayers and hospitals.
TOOLS AND RESOURCES |
AHA RESOURCES
- NEW: AHA 340B Conference Call with HRSA leaders
- NEW: Legislation introduced would weaken 340B
- Factsheet: 340B Drug Discount Program
- 2012 AHA Advocacy Issue Paper
- 340B Program Expansion
- Comment Letter: Exclusion of Orphan Drugs for Certain Covered Entities Under 340B Program
- AHA Testimony: Expiring Medicare Provider Payment Provisions
AHA NEWS
340B IN THE NEWS
OTHER RESOURCES